Department of Cardiology, Gosford Hospital, Gosford, New South Wales, Australia.
J Interv Cardiol. 2009 Oct;22(5):460-5. doi: 10.1111/j.1540-8183.2009.00496.x. Epub 2009 Sep 2.
We report the case of a 69-year-old man who presented with worsening exertional angina where subsequent percutaneous coronary intervention resulted in a coronary arteriovenous fistula. Attempts to occlude the fistula using a relatively conservative management approach with acute reversal of intraprocedural heparin and prolonged balloon inflation unfortunately resulted in extensive coronary artery thrombosis without immediate resolution of the arteriovenous fistula. However, follow-up at 6 months revealed resolution of the fistula. This case study emphasizes the uncommon but potentially life-threatening complications of percutaneous coronary interventions with implications not only relating to the hazards of managing iatrogenic arteriovenous fistula, but reversing intraprocedural heparin using protamine, during any coronary angiogram.
我们报告了一例 69 岁男性患者,其因进行性劳力性心绞痛就诊,随后行经皮冠状动脉介入治疗导致冠状动脉动静脉瘘。试图采用相对保守的管理方法,即急性逆转术中肝素和延长球囊扩张来闭塞瘘管,但不幸导致广泛的冠状动脉血栓形成,瘘管没有立即闭塞。然而,6 个月的随访显示瘘管已闭合。本病例研究强调了经皮冠状动脉介入治疗中罕见但可能危及生命的并发症,不仅涉及到管理医源性动静脉瘘的危险,还涉及到在任何冠状动脉造影术中使用鱼精蛋白逆转术中肝素的问题。